Jitka Mlcochova
Brno, JM, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
Journal: PloS one
Published: January 23, 2017
MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX.
Journal: Oncology letters
Published: January 04, 2017
Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy.
Journal: OncoTargets and therapy
Published: August 25, 2016
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients.
Journal: Anticancer research
Published: July 12, 2016
Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer.
Journal: Oncotarget
Published: July 29, 2015
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.
Journal: Oncotarget
Published: May 17, 2015
MicroRNAs targeting EGFR signalling pathway in colorectal cancer.
Journal: Journal of cancer research and clinical oncology
Published: May 24, 2013
Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
Journal: Journal of cellular and molecular medicine
Published: April 04, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026